157 related articles for article (PubMed ID: 35139628)
1. Calculated parameters for the diagnosis of Wilson disease.
Zulkufli NS; Sthaneshwar P; Chan WK
Singapore Med J; 2023 Mar; 64(3):188-195. PubMed ID: 35139628
[TBL] [Abstract][Full Text] [Related]
2. Biomarkers for diagnosis of Wilson's disease.
Ryan A; Nevitt SJ; Tuohy O; Cook P
Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31743430
[TBL] [Abstract][Full Text] [Related]
3. Copper:caeruloplasmin ratio.
Twomey PJ; Viljoen A; House IM; Reynolds TM; Wierzbicki AS
J Clin Pathol; 2007 Apr; 60(4):441-2. PubMed ID: 17405985
[TBL] [Abstract][Full Text] [Related]
4. Adjusting copper concentrations for caeruloplasmin levels in routine clinical practice.
Twomey PJ; Viljoen A; House IM; Reynolds TM; Wierzbicki AS
J Clin Pathol; 2006 Aug; 59(8):867-9. PubMed ID: 16644878
[TBL] [Abstract][Full Text] [Related]
5. Is it necessary to re-evaluate diagnostic criteria for Wilson disease in children?
Sezer OB; Perk P; Hoşnut FÖ; Köse SK; Özcay F
Turk J Gastroenterol; 2014 Dec; 25(6):690-5. PubMed ID: 25599783
[TBL] [Abstract][Full Text] [Related]
6. Trientine tetrahydrochloride versus penicillamine for maintenance therapy in Wilson disease (CHELATE): a randomised, open-label, non-inferiority, phase 3 trial.
Schilsky ML; Czlonkowska A; Zuin M; Cassiman D; Twardowschy C; Poujois A; Gondim FAA; Denk G; Cury RG; Ott P; Moore J; Ala A; D'Inca R; Couchonnal-Bedoya E; D'Hollander K; Dubois N; Kamlin COF; Weiss KH;
Lancet Gastroenterol Hepatol; 2022 Dec; 7(12):1092-1102. PubMed ID: 36183738
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of Different Diagnostic Test for Identifying Wilson's Disease.
Sonia ZF; Rukunuzzaman M; Karim MB; Yasmin A; Alam R
Mymensingh Med J; 2022 Jan; 31(1):117-123. PubMed ID: 34999690
[TBL] [Abstract][Full Text] [Related]
8. [The diagnostic value and limits of diagnostic parameters for Wilson's disease].
Yang X
Zhonghua Gan Zang Bing Za Zhi; 2017 Dec; 25(12):881-885. PubMed ID: 29325287
[TBL] [Abstract][Full Text] [Related]
9. [Phenotypes and ATP7B gene variants in 316 children with Wilson disease].
Lu ZK; Cheng J; Li SM; Lin YT; Zhang W; Li XZ; Sheng HY; Mao XJ; Mei HF; Zheng RD; Liang CL; Jiang MY; Huang YL; Liu L; Zeng CH
Zhonghua Er Ke Za Zhi; 2022 Apr; 60(4):317-322. PubMed ID: 35385937
[No Abstract] [Full Text] [Related]
10. Re-evaluation of the diagnostic criteria for Wilson disease in children with mild liver disease.
Nicastro E; Ranucci G; Vajro P; Vegnente A; Iorio R
Hepatology; 2010 Dec; 52(6):1948-56. PubMed ID: 20967755
[TBL] [Abstract][Full Text] [Related]
11. Biochemical testing for the diagnosis of Wilson's disease: A systematic review.
Salman HM; Amin M; Syed J; Sarfraz Z; Sarfraz A; Sarfraz M; Farfán Bajaña MJ; Felix M; Cherrez-Ojeda I
J Clin Lab Anal; 2022 Feb; 36(2):e24191. PubMed ID: 34951059
[TBL] [Abstract][Full Text] [Related]
12. The role of calculated non-caeruloplasmin-bound copper in Wilson's disease.
Duncan A; Yacoubian C; Beetham R; Catchpole A; Bullock D
Ann Clin Biochem; 2017 Nov; 54(6):649-654. PubMed ID: 27742851
[TBL] [Abstract][Full Text] [Related]
13. Percentage non-caeruloplasmin bound copper.
Twomey PJ; Wierzbicki AS; House IM; Viljoen A; Reynolds TM
Clin Biochem; 2007 Jun; 40(9-10):749-50. PubMed ID: 17498678
[TBL] [Abstract][Full Text] [Related]
14. Screening for Wilson disease in acute liver failure: a comparison of currently available diagnostic tests.
Korman JD; Volenberg I; Balko J; Webster J; Schiodt FV; Squires RH; Fontana RJ; Lee WM; Schilsky ML;
Hepatology; 2008 Oct; 48(4):1167-74. PubMed ID: 18798336
[TBL] [Abstract][Full Text] [Related]
15. Wilson's disease: A 2017 update.
Poujois A; Woimant F
Clin Res Hepatol Gastroenterol; 2018 Dec; 42(6):512-520. PubMed ID: 29625923
[TBL] [Abstract][Full Text] [Related]
16. Hypoceruloplasminemia-related movement disorder without Kayser-Fleischer rings is different from Wilson disease and not involved in ATP7B mutation.
Lirong J; Jianjun J; Hua Z; Guoqiang F; Yuhao Z; Xiaoli P; Xiaomin Z; Yuwen Z; Yu M; Jie C; Jihong D; Yueshi M; Zhenyao M; Chunjiu Z
Eur J Neurol; 2009 Oct; 16(10):1130-7. PubMed ID: 19572946
[TBL] [Abstract][Full Text] [Related]
17. Age and Serum Creatinine Can Differentiate Wilson Disease Patients with Pseudonormal Ceruloplasmin.
Chen L; Shi Y; Wang N; Lou Z; Pan L; Xu X; Wu C; Han Y; Yang R; Hu W; Ruan B
Int J Clin Pract; 2023; 2023():9344891. PubMed ID: 36915635
[TBL] [Abstract][Full Text] [Related]
18. Long-term evaluation of urinary copper excretion and non-caeruloplasmin associated copper in Wilson disease patients under medical treatment.
Pfeiffenberger J; Lohse CM; Gotthardt D; Rupp C; Weiler M; Teufel U; Weiss KH; Gauss A
J Inherit Metab Dis; 2019 Mar; 42(2):371-380. PubMed ID: 30746719
[TBL] [Abstract][Full Text] [Related]
19. Usefulness of penicillamine-stimulated urinary copper excretion in the diagnosis of adult Wilson's disease.
Foruny JR; Boixeda D; López-Sanroman A; Vázquez-Sequeiros E; Villafruela M; Vázquez-Romero M; Rodríguez-Gandía M; de Argila CM; Camarero C; Milicua JM
Scand J Gastroenterol; 2008; 43(5):597-603. PubMed ID: 18415754
[TBL] [Abstract][Full Text] [Related]
20. Benefits of using exchangeable copper and the ratio of exchangeable copper in a real-world cohort of patients with Wilson disease.
Mariño Z; Molera-Busoms C; Badenas C; Quintero-Bernabeu J; Torra M; Forns X; Artuch R
J Inherit Metab Dis; 2023 Sep; 46(5):982-991. PubMed ID: 37254446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
